22 Bile acids activate the FXR receptor, which then inhibits lipogenesis, gluconeogenesis, and the regulation of insulin sensitivity
In November 2023, the FDA added BPC-157 to its list of substances that cannot be used in compounding under the Federal Food, Drug, and Cosmetic Act, citing insufficient safety data for human use 3
That may sound small, but in an industry where growth is measured in tenths of a percent, its enough to make a difference
While these drugs can be life-changing, they also come with significant costs for the employers who choose to cover them
Enzymes such as Dipeptidyl Peptidase-4 (DPP-4) and Neutral Endopeptidase (NEP) contribute to this process, yielding inactive biological fragments (23)(30) Semaglutide, Serum, and tissue proteases metabolize the polypeptide into amino acids, clearing it from the system and preventing accumulation (23)(21)
Note: These benefits are based on emerging research